Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations

10-01-2014 Business Wire HealthComments (0)


Fibrocell Science, Inc. (NYSE MKT:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for skin diseases and conditions with high unmet medical needs, today announced that Robert Sheroff has been appointed vice president of technical operations for the company. In this newly-created position, Mr. Sheroff will be responsible for managing the growing manufacturing needs of azficel-T, as well as manufacturing genetically-m

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top